JP2009533338A5 - - Google Patents

Download PDF

Info

Publication number
JP2009533338A5
JP2009533338A5 JP2009504144A JP2009504144A JP2009533338A5 JP 2009533338 A5 JP2009533338 A5 JP 2009533338A5 JP 2009504144 A JP2009504144 A JP 2009504144A JP 2009504144 A JP2009504144 A JP 2009504144A JP 2009533338 A5 JP2009533338 A5 JP 2009533338A5
Authority
JP
Japan
Prior art keywords
styrylquinazoline
patent document
compounds
rastinejad
mutant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009504144A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009533338A (ja
Filing date
Publication date
Priority claimed from NZ546477A external-priority patent/NZ546477A/en
Application filed filed Critical
Publication of JP2009533338A publication Critical patent/JP2009533338A/ja
Publication of JP2009533338A5 publication Critical patent/JP2009533338A5/ja
Pending legal-status Critical Current

Links

JP2009504144A 2006-04-07 2007-04-04 置換環縮合アジンおよび癌治療におけるそれらの使用 Pending JP2009533338A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ546477A NZ546477A (en) 2006-04-07 2006-04-07 4-Alkylamino-2-(heterocyclic)quinazolines and their use in cancer therapy
PCT/NZ2007/000077 WO2007117161A1 (en) 2006-04-07 2007-04-04 Substituted ring fused azines and their use in cancer therapy

Publications (2)

Publication Number Publication Date
JP2009533338A JP2009533338A (ja) 2009-09-17
JP2009533338A5 true JP2009533338A5 (enExample) 2010-05-06

Family

ID=38581368

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009504144A Pending JP2009533338A (ja) 2006-04-07 2007-04-04 置換環縮合アジンおよび癌治療におけるそれらの使用

Country Status (8)

Country Link
US (1) US20090318479A1 (enExample)
EP (1) EP2004637A4 (enExample)
JP (1) JP2009533338A (enExample)
CN (1) CN101460490A (enExample)
AU (1) AU2007235751A1 (enExample)
CA (1) CA2648323A1 (enExample)
NZ (1) NZ546477A (enExample)
WO (1) WO2007117161A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012046207A1 (en) * 2010-10-08 2012-04-12 Paraco Technology Limited Anti-parasitic substituted ring fused azine compounds
US8710064B2 (en) * 2011-10-20 2014-04-29 China Medical University 2-aryl-4-quinazolinones and their pharmaceutical compositions
KR20150016406A (ko) 2012-06-07 2015-02-11 에프. 호프만-라 로슈 아게 탄키라제의 피라졸로피리미돈 및 피라졸로피리돈 억제제
WO2013182580A1 (en) 2012-06-07 2013-12-12 F. Hoffmann-La Roche Ag Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase
WO2014143609A1 (en) 2013-03-11 2014-09-18 Bristol-Myers Squibb Company Isoquinolines as potassium ion channel inhibitors
CN105916506B (zh) 2013-11-20 2020-01-07 圣诺康生命科学公司 作为tam家族激酶抑制剂的喹唑啉衍生物
MX2017005346A (es) * 2014-10-29 2017-08-02 Dong A St Co Ltd Nuevos compuestos de piridopirimidinona para modular la actividad catalitica de histona lisina desmetilasas (kdm).
US20170057955A1 (en) * 2015-08-26 2017-03-02 Dong-A Socio Holdings Co., Ltd. Pyridopyrimidinone Compounds for Modulating the Catalytic Activity of Histone Lysine Demethylases (KDMs)
CN107721982B (zh) * 2017-10-16 2019-12-03 中山大学 一种抗肥胖症化合物及其制备方法和应用
CN110483394A (zh) * 2019-09-02 2019-11-22 广东工业大学 一种化合物的应用
CN113072543B (zh) * 2020-01-03 2022-07-22 南方医科大学 一种2-芳杂环基喹唑啉酮类化合物及其制备方法和用途
WO2021155426A1 (en) * 2020-02-04 2021-08-12 TroBio Therapeutics Pty Ltd Quinazoline compounds and the use thereof in the treatment of cancer
WO2022061224A1 (en) 2020-09-21 2022-03-24 Landos Biopharma, Inc. Nlrx1 ligands
CN114044769B (zh) * 2021-11-25 2023-12-12 中山大学 一种β-吲哚喹唑啉酮衍生物及其制备方法和应用
CN117247374A (zh) * 2022-06-10 2023-12-19 成都先导药物开发股份有限公司 一种bcl-xl抑制剂及其制药用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897432A (en) * 1971-04-21 1975-07-29 Merck & Co Inc Substituted benzimidazole derivatives
HUP0201215A2 (en) * 1998-12-02 2002-08-28 Pfizer Prod Inc Methods and compositions for restoring conformational stability of a protein of the p53 family
EP1088818B1 (en) * 1999-10-01 2004-11-03 F. Hoffmann-La Roche Ag Quinolin-4-yl derivatives
CN1186324C (zh) * 2000-04-27 2005-01-26 山之内制药株式会社 稠合杂芳基衍生物
WO2002062767A1 (en) * 2001-02-07 2002-08-15 Sumitomo Pharmaceuticals Company, Limited Novel quinazoline derivatives

Similar Documents

Publication Publication Date Title
JP2009533338A5 (enExample)
CY2020012I1 (el) Προφαρμακα των ενωσεων 2,4-πυριμιδινδιαμινης και οι χρησεις αυτων
DK1853310T3 (da) Anti-Abeta-antistofpræparat
JP2009544651A5 (enExample)
JP2008501714A5 (enExample)
JP2011508438A5 (enExample)
JP2007525988A5 (enExample)
JP2012502876A5 (enExample)
JP2011519271A5 (enExample)
JP2013500200A5 (enExample)
JP2005515295A5 (enExample)
JP2007270374A5 (enExample)
JP2012049345A5 (enExample)
DE602006008312D1 (de) Mesostrukturiertes material mit hohem aluminiumgehalt
JP2007119504A5 (enExample)
JP2009521663A5 (enExample)
JP2009263366A5 (enExample)
JP2009504909A5 (enExample)
IS7341A (is) Trísýklísk 2-pýrimídón efnasambönd, gagnleg sem HIV-víxlritatálmar
NO20054895L (no) Fremgangsmate for fremstilling av karbonmaterialer
JP2009532412A5 (enExample)
JP2008517002A5 (enExample)
JP2009215399A5 (enExample)
ITMI20051155A1 (it) Nuovi composti fluorurati, loro sintesi e uso.
JP2011008097A5 (enExample)